Echostar CORP Form 4 insider transactions

William David Wade, a Director of EchoStar CORP, sold 5,000 shares of common stock on August 12, 2026.

Stephen J Bye, a Director of EchoStar CORP, sold 8,508 shares of common stock on August 7, 2026.

Charles W Ergen and 1 other reported changes in beneficial ownership of EchoStar CORP common stock on July 29, 2026.

Charles W Ergen and 1 other reported changes in beneficial ownership of EchoStar CORP common stock on July 20, 2026.

Telluray Holdings, LLC reported changes in beneficial ownership of EchoStar CORP common stock on July 10, 2026.

Two-Year July 2024 Sats Grat Ergen, a 10% owner of EchoStar CORP, reported a transaction in 18,561,842 shares of common stock on July 10, 2026.

Charles W Ergen and 1 other reported changes in beneficial ownership of EchoStar CORP common stock on July 10, 2026.

EchoStar Corp. reports a Form 4 filing detailing transactions by EVP, Chief Financial Officer Paul W. Orban, including the acquisition of restricted stock units and shares under an employee stock purchase plan.

EchoStar Corp Director James DeFranco acquired restricted stock units and disposed of shares for tax obligations.

EchoStar Corp. director R. Stanton Dodge reported transactions involving Class A Common Stock and stock options, including the automatic exercise of options and withholding of shares for taxes.

EchoStar Corp. Director Lisa W. Hershman reported transactions involving Class A Common Stock and stock options, including the expiration of options and withholding of shares for taxes and exercise price.

EchoStar Corp. reports a Form 4 filing detailing a Restricted Stock Unit (RSU) grant to Director Cantey M. Ergen, alongside updates on various beneficial ownership holdings.

Ergen Two-Year June 2025 SATS GRAT reports distribution of 2,316,533 Class B shares to Charles W. Ergen.

Charles W. Ergen and Cantey M. Ergen have reported changes in beneficial ownership of EchoStar Corp. Class A and Class B common stock, involving various trusts and entities.

EchoStar Chairman Charles Ergen transferred 4.3 million Class B shares into a Grantor Retained Annuity Trust (GRAT) for estate planning purposes.

Chief Legal Officer Dean Manson exercised 10,000 stock options and sold the resulting shares under a pre-arranged 10b5-1 trading plan.

EchoStar CEO Hamid Akhavan exercised stock options and sold a portion of the resulting shares under a pre-arranged Rule 10b5-1 trading plan.

EchoStar Chief Legal Officer Dean Manson exercised options and sold 10,000 shares of Class A Common Stock under a 10b5-1 plan.

EchoStar Corporation Director William David Wade exercised options to acquire 5,000 shares of Class A Common Stock.

Telluray Holdings, LLC acquired 2,925,750 shares of EchoStar Class B Common Stock from the Ergen Two-Year May 2024 SATS GRAT.

The Ergen Two-Year May 2025 SATS GRAT distributed 1,902,790 Class B shares of EchoStar Corporation to Mr. Ergen as an annuity payment.

Chairman Charles Ergen and Cantey Ergen reported internal transfers of Class B common stock related to expiring grantor retained annuity trusts.

EchoStar Corp reports a Form 4 filing detailing a stock option grant to Director and Senior Advisor Cantey Ergen.

EchoStar Corp. director William David Wade was granted 5,000 stock options on April 1, 2026, with immediate vesting.

EchoStar Corp director Tom A. Ortolf was granted a non-employee director stock option for 5,000 shares.

EchoStar Corp. director Lisa W. Hershman reported the acquisition of 5,000 stock options, fully vested upon grant, with an exercise price of $120.60.

EchoStar Corp director R. Stanton Dodge acquired 5,000 stock options on April 1, 2026, with a vesting date of April 1, 2031.

EchoStar Corp. reports that Director Stephen J. Bye was granted 5,000 non-employee director stock options with an exercise price of $120.60.

EchoStar Corp. reports that Director George R. Brokaw was granted 5,000 non-employee director stock options with an exercise price of $120.60.

EchoStar Corp. Director Kathleen Q. Abernathy reported the acquisition of 5,000 stock options with a $120.6 exercise price, vesting immediately.